- BPH’s investee, Cortical Dynamics Ltd, has been granted a key patent for its Brain Anaesthesia Response Monitor (BARM) technology in the United States.
- Cortical has an extensive patent portfolio around its BARM monitoring unit, providing protection to the company’s intellectual property rights in several prominent brain monitoring markets.
- The patent application was published on 28 July 2022 as Publication No. US-2022-0233130 A1.
BPH Energy Limited (ASX:BPH) announced that its investee, Cortical Dynamics Ltd, had been granted a key patent for its Brain Anaesthesia Response Monitor (BARM) technology in the United States.
Cortical has an extensive patent portfolio around its BARM monitoring unit, providing protection to the company’s intellectual property rights in several prominent brain monitoring markets. At present, Cortical holds patents in France, Belgium, Germany, Great Britain, the Netherlands, Switzerland, Italy, Ireland, Australia, New Zealand, the United States, Japan, and China.
Must Read: BPH Energy (ASX:BPH) acquires 10% interest in Clean Hydrogen Technologies
The newly granted patent titled "Apparatus and process for measuring brain activity" was applied under the United States Patent Application No. 17/614701. The patent application was published on 28 July 2022 as Publication No. US-2022-0233130 A1.
Cortical Dynamics is an Australia-based medical device technology company, which targets to disrupt the medical devices industry with a cutting-edge brain function monitoring product. The technology is already widely recognised by leading experts in anaesthesia across the globe.